Theravance Announces Senior Vice President and CFO to Present at Investor Conferences in December

Theravance, Inc., a biopharmaceutical company, has announced that its Senior Vice President and Chief Financial Officer, Michael W. Aguiar, will present at two investor conferences in December 2010. Aguiar will speak at the Piper Jaffray 22nd Annual Health Care Conference in New York and the 2010 Deutsche Bank BioFEST in Boston. The presentations will be webcast live on Theravance's website, and listeners are encouraged to register in advance to access the webcasts.

Key Takeaways:

  • Theravance's Senior Vice President and CFO, Michael W. Aguiar, will present at two investor conferences in December 2010: the Piper Jaffray 22nd Annual Health Care Conference and the 2010 Deutsche Bank BioFEST.
  • The presentations will be held on December 1, 2010, at 9:00 a.m. ET in New York, and on December 14, 2010, at 9:30 a.m. ET in Boston.
  • The presentations will be webcast live on Theravance's website, and listeners are encouraged to register in advance to access the webcasts.
  • Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates, focusing on the discovery, development, and commercialization of small molecule medicines.
  • The company's key programs include the RELOVAIR program and Bifunctional Muscarinic Antagonist-Beta2 Agonist (MABA) program with GlaxoSmithKline, and VIBATIV (telavancin) with Astellas Pharma Inc.

Statistics:

  • Theravance is a biopharmaceutical company with a market capitalization of $X (X is not specified in the sources).
  • The company's pipeline includes several product candidates, including RELOVAIR, MABA, and VIBATIV.
  • Theravance has partnerships with major pharmaceutical companies, including GlaxoSmithKline and Astellas Pharma Inc.
  • The presentations by Aguiar will be webcast live on Theravance's website, and listeners are encouraged to register in advance to access the webcasts.

Sources:

  • Theravance, Inc.
  • Marketwire via COMTEX
  • Mark
  • SmarTrend: Contact your market data provider or go to www.mysmartrend.com
  • Comtex News Network, Inc.